Iberdomide vs. Observation Post Ide-Cel CAR-T

Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients

Near Add Your Location

Sorting 41 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Medical Oncology and Hematology Associates-West Des Moines
Clive, IA
(515) 241-3305
  • Accepting patients
  • Show Principal Investigator
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
MercyOne Des Moines Medical Center
Des Moines, IA
(515) 358-6613
  • Accepting patients
Cedars-Sinai Medical Center - UCLA School of Medicine
Samuel Oschin Comprehensive Cancer Institute
Los Angeles, CA
  • Accepting patients
  • Show Principal Investigator
Nebraska Medicine (Bellevue Medical Center)
Bellevue, NE
  • Accepting patients
  • Show Principal Investigator
Nebraska Medicine (Village Pointe)
Omaha, NE
  • Accepting patients
  • Show Principal Investigator
University of Nebraska Medical Center
Fred & Pamela Buffett Cancer Center
Omaha, NE
  • Accepting patients
  • Show Principal Investigator
Swedish - First Hill Campus
Seattle, WA
  • Accepting patients
Swedish Cancer Institute
Swedish Edmonds Campus
Edmonds, WA
  • Accepting patients
1,276 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.